Skip to content

The Effect of Patient Advocacy Training on Advocacy Skills, Ethical Sensitivity, and Patient Safety Culture in Nurses

The Effect of Patient Advocacy Training on Advocacy Skills, Ethical Sensitivity and Patient Safety Culture in Nurses: A Randomized Controlled Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06969482
Acronym
(RCT)
Enrollment
70
Registered
2025-05-13
Start date
2025-06-21
Completion date
2025-09-19
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Education

Keywords

Patient Advocacy, Ethics, Patient Safety

Brief summary

In this study, the aim is to evaluate the effects of patient advocacy training provided to nurses on their advocacy skills, ethical sensitivity, and patient safety culture level.

Detailed description

This research is a Randomized Controlled Trial (RCT) conducted to investigate the impact of patient advocacy training on nurses by evaluating its effectiveness in increasing nurses' ethical sensitivity and promoting a positive patient safety culture through Bloom's Taxonomy. This study, which will deeply examine the relationship between patient advocacy training, ethical sensitivity, and patient safety culture, aims to provide evidence-based insights that can inform nursing education, training programs, and healthcare policies, ultimately contributing to the improvement of patient outcomes and the overall quality of healthcare delivery.

Interventions

BEHAVIORALmeasuring knowledge level

The study group consists of 70 nurses, each consisting of 35 people. After the routine training of the hospital was given to the control and experimental groups, their consents were obtained and the pre-tests were completed, they were divided into experimental and control groups using simple randomization. The first group of nurses in the control group will not receive any intervention other than the routine training given by the hospital.

OTHEReducational intervention

the effectiveness of training by making measurements after training and comparing them with pre-training results

Sponsors

Selcuk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Control and intervention group nurses will receive routine training provided by the Hospital Education and Quality Unit. After obtaining informed consent and conducting pre-tests, the 70 nurses forming the study group will be randomly assigned to the experimental and control groups using simple randomization. Subsequently, the intervention group of 35 nurses will receive 8 weeks of training. After the training, both groups will undergo post-tests. The tools used for evaluation are as follows: * Personal Information Form * Patient Advocacy Scale for Nurses * Moral Sensitivity Questionnaire * Patient Safety Culture Hospital Questionnaire These tools will be administered and evaluated by a specialist nurse in both groups.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Employees who have no obstacles to participating in the training program

Exclusion criteria

Having worked in the hospital for at least six months

Design outcomes

Primary

MeasureTime frameDescription
Patient advocacy scale, Moral sensitivity survey, Patient Safety Culture Hospital Surveyup to 8 weeksPatient advocacy scale total and sub-dimension scores Moral Sensitivity Questionnaire scale total and sub-dimension scores Evaluation of Patient Safety Culture Hospital Survey is Made Only Based on Positive Response Average Scores
Patient Advocacy Scale for Nurses, Moral Sensitivity Questionnaire (ADA),Hospital Patient Safety Culture Survey (HSOPSC)up to 8 weeksPatient Advocacy Scale for Nurses (HSO) Consists of 39 items and 7 sub-dimensions.- Scoring: Total score ranges from 39 to 195; higher scores indicate higher level of advocacy * Reliability: Cronbach alpha coefficient 0.95; ranges from 0.82 to 0.92 for sub-dimensions Moral Sensitivity Questionnaire (ADA) Consists of 30 items and 6 sub-dimensions,- Scoring: Total score ranges from 30 to 210; lower scores indicate higher ethical sensitivity * Reliability: Cronbach alpha coefficient ranges from 0.82 to 0.84; test-retest correlation coefficient ranges from 0.81 to 0.99 Patient Safety Culture Survey (HSOPSC) * Contains a total of 42 items, assesses patient safety culture in 12 dimensions, Scoring: Each item is assessed using a 5-point Likert scale (1=Strongly disagree, 5=Strongly agree) Reliability: Validity and reliability studies of the Turkish version have been conducted

Secondary

MeasureTime frameDescription
Educational interventionafter 8 weeksPatient Advocacy Scale for Nurses (HSO) Consists of 39 items and 7 sub-dimensions.- Scoring: Total score ranges from 39 to 195; higher scores indicate higher level of advocacy * Reliability: Cronbach alpha coefficient 0.95; ranges from 0.82 to 0.92 for sub-dimensions Moral Sensitivity Questionnaire (ADA) Consists of 30 items and 6 sub-dimensions,- Scoring: Total score ranges from 30 to 210; lower scores indicate higher ethical sensitivity * Reliability: Cronbach alpha coefficient ranges from 0.82 to 0.84; test-retest correlation coefficient ranges from 0.81 to 0.99 Patient Safety Culture Survey (HSOPSC) * Contains a total of 42 items, assesses patient safety culture in 12 dimensions, Scoring: Each item is assessed using a 5-point Likert scale (1=Strongly disagree, 5=Strongly agree) Reliability: Validity and reliability studies of the Turkish version have been conducted
Post-tests after 8 weeks of training1 monthPre-tests of Both Groups Comparison of Experimental Group According to Follow-up Times Post-tests of Both Groups Should Also Be Done and Reported

Contacts

Primary ContactNeslihan Ş Doctoral student, Doctoral student
neslihansah42@gmail.com+905447938010
Backup ContactEmel F Doç.Dr.Emel Filiz, Associate Professor
efiliz@selcuk.edu.tr+905052875800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026